Ozturk NB, Bartosek N, Toruner MD, Mumtaz A, Simsek C, Dao D, et al. Approach to liver transplantation: is there a difference between East and West? J Clin Med. 2024;13(7):1890.

Article  PubMed  PubMed Central  Google Scholar 

O’Neill S, Roebuck A, Khoo E, Wigmore SJ, Harrison EM. A meta-analysis and meta-regression of outcomes including biliary complications in donation after cardiac death liver transplantation. Transpl Int. 2014;27(11):1159–74. https://doi.org/10.1111/tri.12403.

Kalisvaart M, de Haan JE, Polak WG, Metselaar HJ, Wijnhoven BPL, IJzermans JNM, et al. Comparison of postoperative outcomes between donation after circulatory death and donation after brain death liver transplantation using the comprehensive complication index. Ann Surg. 2017;266(5):772–8. https://doi.org/10.1097/SLA.0000000000002419.

Kalisvaart M, de Haan JE, Polak WG, IJzermans JNM, Gommers D, Metselaar HJ, et al. Onset of donor warm ischemia time in donation after circulatory death liver transplantation: hypotension or hypoxia? Liver Transpl. 2018;24(8):1001–10. https://doi.org/10.1002/lt.25287.

NTS. Cijferoverszicht 2019. NTS. https://www.transplantatiestichting.nl/files/2020-06/NTS_cijferbijlage_jaarverslag_2019.pdf. Accessed 23 Mar 2022.

Golubnitschaja O, Baban B, Boniolo G, Wang W, Bubnov R, Kapalla M, et al. Medicine in the early twenty-first century: paradigm and anticipation-EPMA position paper 2016. EPMA J. 2016;7(1):23.

Schlegel A, Kalisvaart M, Scalera I, Laing RW, Mergental H, Mirza DF, et al. The UK DCD Risk Score: a new proposal to define futility in donation-after-circulatory-death liver transplantation. J Hepatol. 2018;68(3):456–64.

Article  PubMed  Google Scholar 

Dutkowski P, Schlegel A, Slankamenac K, Oberkofler CE, Adam R, Burroughs AK, et al. The use of fatty liver grafts in modern allocation systems: risk assessment by the balance of risk (BAR) score. Ann Surg. 2012;256(5):861–9.

Article  PubMed  Google Scholar 

van de Leemkolk FEM, Schurink IJ, Dekkers OM, Oniscu GC, Alwayn IPJ, Ploeg RJ, et al. Abdominal normothermic regional perfusion in donation after circulatory death: a systematic review and critical appraisal. Transplantation. 2020;104(9):1776–91. https://doi.org/10.1097/TP.0000000000003345.

Croome KP, Brown TE, Mabrey RL, Sonnenwald SL, Burns JM, Mao SA, et al. Development of a portable abdominal normothermic regional perfusion (A-NRP) program in the United States. Liver Transpl. 2023;29(12):1282–91. https://doi.org/10.1097/LVT.0000000000000156.

Muller X, Mohkam K, Mueller M, Schlegel A, Dondero F, Sepulveda A, et al. Hypothermic oxygenated perfusion versus normothermic regional perfusion in liver transplantation from controlled donation after circulatory death: first international comparative study. Ann Surg. 2020;272(5):751–8. https://doi.org/10.1097/SLA.0000000000004268.

Watson CJE, Hunt F, Messer S, Currie I, Large S, Sutherland A, et al. In situ normothermic perfusion of livers in controlled circulatory death donation may prevent ischemic cholangiopathy and improve graft survival. Am J Transplant. 2019;19(6):1745–58. https://doi.org/10.1111/ajt.15241.

Schurink IJ, de Goeij FHC, Habets LJM, van de Leemkolk FEM, van Dun CAA, Oniscu GC, et al. Salvage of declined extended-criteria DCD livers using in situ normothermic regional perfusion. Ann Surg. 2022;276(4):e223–30. https://doi.org/10.1097/SLA.000000000000561100000658-202210000-00022.

Hessheimer AJ, de la Rosa G, Gastaca M, Ruiz P, Otero A, Gomez M, et al. Abdominal normothermic regional perfusion in controlled donation after circulatory determination of death liver transplantation: outcomes and risk factors for graft loss. Am J Transplant. 2022;22(4):1169–81. https://doi.org/10.1111/ajt.16899.

Foley DP, Fernandez LA, Leverson G, Anderson M, Mezrich J, Sollinger HW, et al. Biliary complications after liver transplantation from donation after cardiac death donors: an analysis of risk factors and long term outcomes from a single center. Ann Surg. 2011;253(4):817.

Article  PubMed  Google Scholar 

Dubbeld J, Hoekstra H, Farid W, Ringers J, Porte RJ, Metselaar HJ, et al. Similar liver transplantation survival with selected cardiac death donors and brain death donors. J Br Surg. 2010;97(5):744–53.

Article  CAS  Google Scholar 

Schurink IJ, van de Leemkolk FEM, Fondevila C, De Carlis R, Savier E, Oniscu GC, et al. Donor eligibility criteria and liver graft acceptance criteria during normothermic regional perfusion: a systematic review. Liver Transpl. 2022. https://doi.org/10.1002/lt.26512.

Stockmann M, Lock JF, Riecke B, Heyne K, Martus P, Fricke M, et al. Prediction of postoperative outcome after hepatectomy with a new bedside test for maximal liver function capacity. Ann Surg. 2009;250(1):119–25. https://doi.org/10.1097/SLA.0b013e3181ad85b5.

Schurink IJ, de Haan JE, Willemse J, Mueller M, Doukas M, Roest H, et al. A proof of concept study on real-time LiMAx CYP1A2 liver function assessment of donor grafts during normothermic machine perfusion. Sci Rep. 2021;11(1):23444. https://doi.org/10.1038/s41598-021-02641-010.1038/s41598-021-02641-0.

Buechter M, Thimm J, Baba HA, Bertram S, Willuweit K, Gerken G, et al. Liver maximum capacity: a novel test to accurately diagnose different stages of liver fibrosis. Digestion. 2019;100(1):45–54. https://doi.org/10.1159/000493573.

Lock JF, Schwabauer E, Martus P, Videv N, Pratschke J, Malinowski M, et al. Early diagnosis of primary nonfunction and indication for reoperation after liver transplantation. Liver Transpl. 2010;16(2):172–80. https://doi.org/10.1002/lt.21973.

Blank V, Petroff D, Boehlig A, Heinze A, Karlas T, Berg T, et al. Clinical implications of hepatic structure and function evaluation based on vibration-controlled transient elastography and liver maximum function capacity test in patients with nonalcoholic fatty liver disease. Eur J Gastroenterol Hepatol. 2022;34(6):686–92. https://doi.org/10.1097/MEG.0000000000002347.

Kreimeyer H, Buechter M, Best J, Gieseler RK, Katsounas A, Sowa JP, et al. Performance of the LiMAx test, fibrinogen, and transient elastography in patients with acute liver injury. Dig Dis. 2022. https://doi.org/10.1159/000523696.

Clausius R. Ueber die Art der Bewegung, welche wir Wärme nennen. Ann Phys. 1857;176(3):353–80.

Article  Google Scholar 

van Rijn R, Schurink IJ, de Vries Y, van den Berg AP, Cortes Cerisuelo M, Darwish Murad S, et al. Hypothermic machine perfusion in liver transplantation - a randomized trial. N Engl J Med. 2021;384(15):1391–401. https://doi.org/10.1056/NEJMoa2031532.

Aggarwal S, Kang Y, Freeman JA, Fortunato FL, Pinsky MR. Postreperfusion syndrome: cardiovascular collapse following hepatic reperfusion during liver transplantation. Transplant Proc. 1987;19(4 Suppl 3):54–5.

PubMed  CAS  Google Scholar 

Olthoff KM, Kulik L, Samstein B, Kaminski M, Abecassis M, Emond J, et al. Validation of a current definition of early allograft dysfunction in liver transplant recipients and analysis of risk factors. Liver Transpl. 2010;16(8):943–9.

Article  PubMed  Google Scholar 

Braat AE, Blok JJ, Putter H, Adam R, Burroughs AK, Rahmel AO, et al. The Eurotransplant donor risk index in liver transplantation: ET-DRI. Am J Transplant. 2012;12(10):2789–96.

Article  PubMed  CAS  Google Scholar 

Justo I, Nutu A, García-Conde M, Marcacuzco A, Manrique A, Calvo J, et al. Incidence and risk factors of primary non-function after liver transplantation using grafts from uncontrolled donors after circulatory death. Clin Transplant. 2021;35(1):e14134.

Article  PubMed  Google Scholar 

Fondevila C, Hessheimer AJ, Flores E, Ruiz A, Mestres N, Calatayud D, et al. Applicability and results of Maastricht type 2 donation after cardiac death liver transplantation. Am J Transplant. 2012;12(1):162–70.

Article  PubMed  CAS  Google Scholar 

Uhlen M, Fagerberg L, Hallstrom BM, Lindskog C, Oksvold P, Mardinoglu A, et al. Proteomics tissue-based map of the human proteome. Science. 2015;347(6220):1260419. https://doi.org/10.1126/science.1260419.

Ruiz P, Valdivieso A, Palomares I, Prieto M, Ventoso A, Salvador P, et al. Similar results in liver transplantation from controlled donation after circulatory death donors with normothermic regional perfusion and donation after brain death donors: a case-matched single-center study. Liver Transpl. 2021;27(12):1747–57. https://doi.org/10.1002/lt.26281.

De Carlis R, Schlegel A, Frassoni S, Olivieri T, Ravaioli M, Camagni S, et al. How to preserve liver grafts from circulatory death with long warm ischemia? A retrospective Italian cohort study with normothermic regional perfusion and hypothermic oxygenated perfusion. Transplantation. 2021;105(11):2385–96. https://doi.org/10.1097/TP.0000000000003595.

Schurink IJ, de Haan JE, Willemse J, Mueller M, Doukas M, Roest H, et al. A proof of concept study on real-time LiMAx CYP1A2 liver function assessment of donor grafts during normothermic machine perfusion. Sci Rep. 2021;11(1):1–12.

Article  Google Scholar 

Kerforne T, Allain G, Giraud S, Bon D, Ameteau V, Couturier P, et al. Defining the optimal duration for normothermic regional perfusion in the kidney donor: a porcine preclinical study. Am J Transplant. 2019;19(3):737–51. https://doi.org/10.1111/ajt.15063.

Hessheimer AJ, Gastaca M, Minambres E, Colmenero J, Fondevila C, S. W. G. o. D. C. D. in representation of the. Donation after circulatory death liver transplantation: consensus statements from the Spanish liver transplantation society. Transpl Int. 2020;33(8): 902–916. https://doi.org/10.1111/tri.13619.

Stockmann M, Lock JF, Malinowski M, Niehues SM, Seehofer D, Neuhaus P. The LiMAx test: a new liver function test for predicting postoperative outcome in liver surgery. HPB. 2010;12(2):139–46. https://doi.org/10.1111/j.1477-2574.2009.00151.x.

Czigany Z, Uluk D, Pavicevic S, Lurje I, Froněk J, Keller T, et al. Improved outcomes after hypothermic oxygenated machine perfusion in liver transplantation–long-term follow-up of a multicenter randomized controlled trial. Hepatol Commun. 2024;8(2):e0376.

Sampaziotis F, Muraro D, Tysoe OC, Sawiak S, Beach TE, Godfrey EM, et al. Cholangiocyte organoids can repair bile ducts after transplantation in the human liver. Science. 2021;371(6531):839–46.

Stine JG, Argo CK, Pelletier SJ, Maluf DG, Northup PG. Liver transplant recipients with portal vein thrombosis receiving an organ from a high-risk donor are at an increased risk for graft loss due to hepatic artery thrombosis. Transpl Int. 2016;29(12):1286–95.

Article  PubMed  Google Scholar 

Delmonico FL, Jenkins RL, Freeman R, Vacanti J, Bradley J, Dienstag JL, et al. The high-risk liver allograft recipient: should allocation policy consider outcome? Arch Surg. 1992;127(5):579–84.

Article  PubMed  CAS  Google Scholar 

Sundaram V, Shah P, Wong RJ, Karvellas CJ, Fortune BE, Mahmud N, et al. Patients with acute on chronic liver failure grade 3 have greater 14-day waitlist mortality than status-1a patients. Hepatology. 2019;70(1):334–45.

Beumer BR, Polak WG, de Man RA, Metselaar HJ, van Klaveren D, Labrecque J, et al. Impact of waiting time on post-transplant survival for recipients with hepatocellular carcinoma: a natural experiment randomized by blood group. JHEP Reports. 2023;5(2):100629.